262P Pragmatic clinical trial assessing response to neoadjuvant taxotere and trastuzumab in Nigerian women with HER2-positive breast cancer (ARETTA): First report from the Nigerian breast cancer study group

كما طُبع: A. Ibraheem

• University of Ibadan (NG)

كما طُبع: A. Folasire

• University of Ibadan (NG)

كما طُبع: A. Adeniji-Sofoluwe

• Lagos University Teaching Hospital (NG)

كما طُبع: T. Olajide

• Lagos State University Teaching Hospital (NG)

• Obafemi Awolowo University (NG)

كما طُبع: A. Komolafe

• Obafemi Awolowo University Teaching Hospitals Complex (NG)
• Obafemi Awolowo University (NG)

كما طُبع: A. Omisore

• University of Ibadan (NG)

كما طُبع: M. Ajani

• University of Lagos (NG)

• University of Lagos (NG)

كما طُبع: F. Abdulkareem

كما طُبع: O. Balogun

كما طُبع: T. Karrison

كما طُبع: C. Olopade

• Lagos State University Teaching Hospital (NG)

كما طُبع: J. Obafunwa

كما طُبع: O. Olopade